PureTech Health (LON:PRTC) Insider Sharon Barber-Lui Buys 29,868 Shares

PureTech Health plc (LON:PRTCGet Free Report) insider Sharon Barber-Lui acquired 29,868 shares of the stock in a transaction dated Tuesday, July 7th. The shares were bought at an average price of GBX 119 per share, with a total value of £35,542.92.

PureTech Health Price Performance

LON PRTC opened at GBX 120 on Thursday. The company has a market cap of £292.10 million, a price-to-earnings ratio of -2.61 and a beta of 0.79. The company has a debt-to-equity ratio of 6.33, a current ratio of 6.59 and a quick ratio of 2.51. The stock’s fifty day moving average price is GBX 129.88 and its 200 day moving average price is GBX 127.13. PureTech Health plc has a 1 year low of GBX 104.71 and a 1 year high of GBX 148.

PureTech Health Company Profile

(Get Free Report)

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.

Further Reading

Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.